{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "regularMarketChangePercent": -1.5748017, "regularMarketPrice": 1.25, "currency": "EUR", "exchange": "FRA", "shortName": "D.WESTERN THERAPEUT.INST.", "longName": "D. Western Therapeutics Institute, Inc.", "messageBoardId": "finmb_52322388", "exchangeTimezoneName": "Europe/Berlin", "exchangeTimezoneShortName": "CEST", "gmtOffSetMilliseconds": 7200000, "market": "dr_market", "esgPopulated": false, "marketState": "REGULAR", "tradeable": false, "cryptoTradeable": false, "firstTradeDateMilliseconds": 1305525600000, "priceHint": 4, "regularMarketChange": -0.01999998, "regularMarketTime": 1683871418, "regularMarketDayHigh": 1.25, "regularMarketDayRange": "1.25 - 1.25", "regularMarketDayLow": 1.25, "regularMarketVolume": 300, "regularMarketPreviousClose": 1.27, "bid": 1.26, "ask": 1.47, "bidSize": 100, "askSize": 100, "fullExchangeName": "Frankfurt", "financialCurrency": "JPY", "regularMarketOpen": 1.25, "averageDailyVolume3Month": 0, "averageDailyVolume10Day": 0, "fiftyTwoWeekLowChange": 0.00999999, "fiftyTwoWeekLowChangePercent": 0.008064508, "fiftyTwoWeekRange": "1.24 - 2.4", "fiftyTwoWeekHighChange": -1.1500001, "fiftyTwoWeekHighChangePercent": -0.4791667, "fiftyTwoWeekLow": 1.24, "fiftyTwoWeekHigh": 2.4, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -0.06, "sharesOutstanding": 31323200, "bookValue": 60.121, "fiftyDayAverage": 1.3896, "fiftyDayAverageChange": -0.13960004, "fiftyDayAverageChangePercent": -0.10046059, "twoHundredDayAverage": 1.65645, "twoHundredDayAverageChange": -0.40645003, "twoHundredDayAverageChangePercent": -0.24537416, "marketCap": 41646248, "priceToBook": 0.020791404, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "symbol": "6DW.F"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "CK21 Hirokoujifushimi Building", "address2": "7th Floor 1-18-11, Nishiki Naka-ku", "city": "Nagoya", "zip": "460-0003", "country": "Japan", "phone": "81 5 2218 8785", "fax": "81 5 2202 1866", "website": "https://www.dwti.co.jp", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "D. Western Therapeutics Institute, Inc., a biotechnology company, focuses on developing drugs to serve patients worldwide. The company offers GLANATEC, an ophthalmic solution for the treatment of glaucoma/ocular hypertension; and DW-1002, an ophthalmic surgical adjuvant for cataract surgeries, and ILM staining and peeling. It is also developing H-1337, a multikinase inhibitor that has completed Phase I/IIa clinical trials for the treatment of glaucoma/ocular hypertension; K-134, an antiplatelet agent, which has completed Phase IIb trials to treat arteriosclerosis obliterans; DW-1001, an ophthalmic treatment agent in nonclinical studies; and DW-5LBT, a lidocaine patch for neuropathic pain after shingles. The company was founded in 1999 and is headquartered in Nagoya, Japan.", "fullTimeEmployees": 20, "companyOfficers": [{"maxAge": 1, "name": "Mr. Yuichi  Hidaka", "age": 49, "title": "Pres, CEO & Representative Director", "yearBorn": 1973, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Tetsuya  Kawakami", "age": 57, "title": "GM of Admin. Division & Director", "yearBorn": 1965, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "maxAge": 86400}}], "error": null}}